Metabolic and bone effects after administration of ipriflavone and salmon calcitonin in postmenopausal osteoporosis
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 49 (10) , 465-468
- https://doi.org/10.1016/0753-3322(96)82691-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effects of ipriflavone administration on bone mass and metabolism in ovariectomized womenJournal of Endocrinological Investigation, 1993
- Effect of ipriflavone on bone mass in elderly osteoporotic womenBone and Mineral, 1992
- Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacteriumBone and Mineral, 1992
- Effects of ipriflavone on bone remodeling in primary hyperparathyroidismBone and Mineral, 1992
- Ipriflavone inhibits osteoclast differentiation in parathyroid transplanted parietal bone of ratsCalcified Tissue International, 1992
- Effects of ipriflavone and its metabolites on a clonal osteoblastic cell lineJournal of Bone and Mineral Research, 1991
- The effect of ipriflavone (TC-80) on bone resorption in tissue cultureJournal of Bone and Mineral Research, 1986
- Effect of ipriflavone on glucocorticoid-induced osteoporosis in ratsLife Sciences, 1986